Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Bayer claims novel vanilloid VR1 receptor antagonists for urological disorders

Aug. 25, 2005

Patents report therapeutic agents for thrombotic disorders

Aug. 24, 2005

Recent patents describe novel antiinfective agents

Aug. 24, 2005

TLR2 antagonists emerge from Eisai R&D

Aug. 24, 2005

Novel therapeutics for cardiovascular diseases reported

Aug. 23, 2005

Companies disclose new treatments for diabetes

Aug. 23, 2005

Novel agents for treating eating disorders claimed by sanofi-aventis

Aug. 23, 2005

New agents for arthritis, inflammatory disorders, etc., in early development

Aug. 22, 2005

Novel agents for respiratory disorders claimed in recent patents

Aug. 22, 2005

New anti-HCV agents prepared and tested

Aug. 22, 2005

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...